Search Results - "MITTENDORF, Thomas"

Evolution of cost structures in rheumatoid arthritis over the past decade by Huscher, Dörte, Mittendorf, Thomas, von Hinüber, Ulrich, Kötter, Ina, Hoese, Guido, Pfäfflin, Andrea, Bischoff, Sascha, Zink, Angela

“…To estimate the changes in direct and indirect costs induced by patients with rheumatoid arthritis (RA) in German rheumatology, between 2002 and 2011. To…”
Get more information

The role of biosimilars in the treatment of rheumatic diseases by Dörner, Thomas, Strand, Vibeke, Castañeda-Hernández, Gilberto, Ferraccioli, Gianfranco, Isaacs, John D, Kvien, Tore K, Martin-Mola, Emilio, Mittendorf, Thomas, Smolen, Josef S, Burmester, Gerd R

“…The first biological therapeutics in rheumatology are approaching patent expiration, encouraging development of 'follow-on' versions, known as 'biosimilars'…”
Get more information

Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany by Eidt-Koch, Daniela, Mittendorf, Thomas, Greiner, Wolfgang

“…Quality of life is recognized as an important additional outcome measure in clinical trials and health economic evaluations. The EQ-5D is an important generic…”
Get full text

Application study of the EQ-5D-5L in oncology: Linking self-reported quality of life of patients with advanced or metastatic colorectal cancer to clinical data from a German tumor registry by Borchert, Kathrin, Jacob, Christian, Wetzel, Natalie, Jänicke, Martina, Eggers, Egbert, Sauer, Annette, Marschner, Norbert, Altevers, Julia, Mittendorf, Thomas, Greiner, Wolfgang

“…Background: The EQ-5D-5L questionnaire is used in oncology to generate health-related quality of life (HRQoL) weights and corresponding health states. The…”
Get full text

A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective by Nuijten, Mark, MD, PhD, MBA, Mittendorf, Thomas, PhD

“…Abstract Objective: This analysis compared the cost-effectiveness of interferon beta-1a (IFNβ-1a) 44 μg SC with that of other available first-line treatments…”
Get full text

Cost-Effectiveness of Targeted Therapy With Cetuximab in Patients With K- ras Wild-Type Colorectal Cancer Presenting With Initially Unresectable Metastases Limited to the Liver in a German Setting by Asseburg, Christian, PhD, Frank, Martin, MBA, Köhne, Claus-Henning, MD, Hartmann, Jörg Thomas, MD, Griebsch, Ingolf, PhD, Mohr, Andrea, MD, Osowski, Ulrike, MD, Schulten, Jeltje, MD, MBA, Mittendorf, Thomas, PhD

“…Abstract Background In patients with metastases limited to the liver (liver-limited disease [LLD]), effective therapies such as monoclonal antibodies combined…”
Get full text

Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine by Prenzler, Anne, Yen, Linnette, Mittendorf, Thomas, von der Schulenburg, J-Matthias

“…The treatment of ulcerative colitis (UC) can place a substantial financial burden on healthcare systems. The anti-inflammatory compound 5-aminosalicylic acid…”
Get full text

Improvement and longterm maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritis by MITTENDORF, Thomas, DIETZ, Birgitta, STERZ, Raimund, KUPPER, Hartmut, CIFALDI, Mary A, VON DER SCHULENBURG, Johann-Matthias

“…OBJECTIVE: In patients with longstanding severe rheumatoid arthritis (RA) receiving chronic treatment with adalimumab, health related quality of life (HRQOL)…”
Get full text

Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals by Riepe, Matthias W, Mittendorf, Thomas, Förstl, Hans, Frölich, Lutz, Haupt, Martin, Leidl, Reiner, Vauth, Christoph, von der Schulenburg, Matthias Graf

“…The number of individuals at risk for dementia will probably increase in ageing societies as will the array of preventive and therapeutic options, both however…”
Get full text

Why Is It So Difficult to Evaluate Nursing Interventions in Dementia by Schwarzbach, Christoph, Förstl, Hans, Nocon, Marc, Mittendorf, Thomas

“…Two recent health technology assessment (HTA) reports published in Germany focused on non-pharmacological interventions for patients with dementia. One of the…”
Get full text

Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness: A Systematic Review by Frank, Martin, Mittendorf, Thomas

“…Background Metastatic colorectal cancer (mCRC) imposes a substantial health burden on individual patients and society. Furthermore, rising costs in oncology…”
Get full text

Scientific Guidelines and Their Implementation in Health Policy by von der Schulenburg, J.-Matthias Graf, PhD, Mittendorf, Thomas, PhD, Vauth, Christoph, MSc, Greiner, Wolfgang, PhD

Get full text

Modeling rheumatoid arthritis using different techniques: A review of model construction and results by Scholz, Stefan, Mittendorf, Thomas

“…Background: Rheumatoid arthritis (RA) is a chronic, inflammatory disease with severe effects on the functional ability of patients. Due to the prevalence of…”
Get full text

Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness by Frank, Ma, Mittendorf, Thomas

“…Background Metastatic colorectal cancer (mCRC) imposes a substantial health burden on individual patients and society. Furthermore, rising costs in oncology…”
Get full text

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: Persistence and dosing patterns in Germany by Neubauer, Sarah, Cifaldi, Mary, Mittendorf, Thomas, Ganguli, Arijit, Wolff, Malte, Zeidler, Jan

“…Objective: To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and…”
Get full text

Measuring economic consequences of preterm birth: Methodological recommendations for the evaluation of personal burden on children and their caregivers by Hodek, Jan-Marc, von der Schulenburg, J.-Matthias, Mittendorf, Thomas

“…This study aims to identify the impact of a preterm birth on financial and emotional burden from the families' perspective. Additionally, a comprehensive…”
Get full text

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus by von der Schulenburg, J.-Matthias Graf, PhD, Greiner, Wolfgang, PhD, Jost, Fred, MSc, Klusen, Norbert, PhD, Kubin, Maria, MD, Leidl, Reiner, PhD, Mittendorf, Thomas, PhD, Rebscher, Herbert, PhD, Schoeffski, Oliver, PhD, Vauth, Christoph, MSc, Volmer, Timm, DVM, MPH, Wahler, Steffen, MD, Wasem, Juergen, PhD, Weber, Christian, MD

“…Financial restrictions and a stronger focus on outcomes assessment require rational decision regarding the allocation of resources in the health care system…”
Get full text

Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia by Plagemann, Thomas, Prenzler, Anne, Mittendorf, Thomas

“…Because of an elevated serum phosphate level, patients who suffer from chronic kidney failure frequently tend tohave cardiovascular calcification and are…”
Get full text

Patient preferences in allergy immunotherapy (AIT) in Germany: A discrete-choice-experiment by Damm, Kathrin, Volk, Janina, Horn, Andreas, Allam, Jean-Pierre, Troensegaard-Petersen, Ninette, Serup-Hansen, Niels, Winkler, Thomas, Thiessen, Ivonne, Borchert, Kathrin, Wüstenberg, Eike G, Mittendorf, Thomas

“…Background: Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only…”
Get full text

Cost of illness in rheumatoid arthritis in Germany in 1997―98 and 2002: cost drivers and cost savings by KIRCHHOFF, Timm, RUOF, Jörg, MITTENDORF, Thomas, RIHL, Markus, BERNATECK, Michael, MAU, Wilfried, ZEIDLER, Henning, SCHMIDT, Reinhold E, MERKESDAL, Sonja

“…Comparison of overall RA-related costs and of relative contribution of single-cost domains before and after the introduction of TNF-blocking agents in Germany…”
Get full text